康芝药业：2025年上半年净亏损5408.17万元

Group 1 - The company reported a revenue of 232 million yuan for the first half of 2025, representing a year-on-year increase of 5.56% [1] - The net loss for the company was 54.08 million yuan, compared to a net loss of 101 million yuan in the same period last year [1] - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves [1]